Star Chenoweth, PA
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,845 of the $2,889 with a category attached, or 63.9%. Medtronic accounts for 90.1% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2023 at $2,502 and has fallen 94.1% since, to $147 in 2025.
Across 47 payments — averaging $61.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- AbbVie$150
- Indivior Inc.$64
- Abbott$31
- Pfizer$29
- Biohaven Pharmaceutical Holding Company Ltd.$13
What the payments were for
- Travel & lodging$1,84564%
- Food & beverage$1,04436%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 31 | $2,603 |
| AbbVie | 8 | $150 |
| Indivior Inc. | 3 | $64 |
| Abbott | 2 | $31 |
| Pfizer | 2 | $29 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$1,946
How this compares
$2,889 in reported general payments places this provider in the 75th percentile of 91 surgical providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 179 | $8,552 |
| Pregabalin | 104 | $6,418 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 197 | $6,042 |
| Buprenorphine Hcl | 43 | $4,447 |
| Gabapentin | 175 | $2,407 |
| Celecoxib | 48 | $2,046 |
| Oxycodone Hcl | 88 | $1,650 |
| Naloxone Hcl | 23 | $1,446 |
| Tramadol Hcl | 50 | $683 |
| Tramadol Hcl ErTramadol Hcl | 11 | $487 |
| Tizanidine Hcl | 41 | $427 |
| Methadone Hcl | 23 | $254 |
| Duloxetine Hcl | 17 | $238 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 16 | $188 |
| Meloxicam | 41 | $186 |
Paid to pharmacies, not to this prescriber.
Other surgical in Elko
- Heather RohrerLas Vegas$253K
- Andrew RackhamHenderson$34K
- Andrea EghterafiLas Vegas$11K
- Kellie KoppReno$10K
- Kasie PalmerLas Vegas$8K
- Jeffrey HaynesLas Vegas$8K
- Lee PhanHenderson$8K
- Darin DutsonLas Vegas$8K
- Curt EricksonReno$7K
- Anastasia van LeuvenLas Vegas$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.